课题基金 / 基金详情

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
嘧啶核苷磷酸化酶在化疗中的应用
批准号:
3178387
负责人:
SHIH HSI CHU
金额:
$14.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1993-11-30

项目摘要

项目成果

SHIH HSI CHU的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objectives of this grant proposal are: 1. Chemical synthesis of analogs and derivatives of BAU (5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), potent inhibitors of uridine phosphorylase and potentiators of the anti-tumor action of FUdR, designed to improve facility of clinical use, to produce new anti-tumor drugs and pro-drugs, and to explore further their biological properties. 2. Biological testing of these new agents as inhibitors of uridine phosphorylase and, where indicated, thymidine phosphorylase, as transport inhibitors, anti-tumor agents and potentiators both in vitro and in vivo, and as tools for obtaining new biochemical knowledge related to nucleic acid metabolism. These studies will be performed in collaboration with colleagues in the Roger Williams Cancer Center.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
苄基环尿苷的新类似物,来自人和小鼠肝脏的尿苷磷酸化酶的特异性和有效抑制剂。
DOI: 10.1016/0006-2952(87)90150-x
发表时间: 1987
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Naguib,FN, elKouni,MH, Chu,SH, Cha,S]
通讯作者: Cha,S
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
N-糖苷键构象和戊糖部分的修饰对核苷配体与尿苷磷酸化酶结合的影响。
DOI: --
发表时间: 1988
期刊: Molecular pharmacology
影响因子: 3.6
作者: [elKouni,MH, Naguib,FN, Chu,SH, Cha,SM, Ueda,T, Gosselin,G, Imbach,JL, Shealy,YF, Otter,BA]
通讯作者: Otter,BA
Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
5-benzyloxybenzyloxybenzylcyclouridine 在人结肠癌细胞系中增强 5-氟-2-脱氧尿苷抗肿瘤活性。
DOI: --
发表时间: 1992
期刊: Cancer research
影响因子: 11.2
作者: [Chu,E, Chu,MY, Darnowski,JW, Chen,ZH, Pan,BC, Chu,SH]
通讯作者: Chu,SH
Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.
苄基环尿苷对大肠杆菌尿苷磷酸化酶的抑制。
DOI: 10.1016/0006-2952(86)90675-1
发表时间: 1986
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Park,KS, elKouni,MH, Krenitsky,TA, Chu,SH, Cha,S]
通讯作者: Cha,S
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
  • 批准号:
    3178386
  • 项目类别:
  • 资助金额:
    $14.23万
  • 财政年份:
    1985
  • 负责人:
    SHIH HSI CHU
  • 依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
  • 批准号:
    3178378
  • 项目类别:
  • 资助金额:
    $9.5万
  • 财政年份:
    1985
  • 负责人:
    SHIH HSI CHU
  • 依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
  • 批准号:
    3178385
  • 项目类别:
  • 资助金额:
    $10.12万
  • 财政年份:
    1985
  • 负责人:
    SHIH HSI CHU
  • 依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
  • 批准号:
    3178384
  • 项目类别:
  • 资助金额:
    $9.51万
  • 财政年份:
    1985
  • 负责人:
    SHIH HSI CHU
  • 依托单位: